This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Pathology of Head & Neck  • Salivary Gland Disorders  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

Arch Otolaryngol Head Neck Surg. 2004;130:476-477.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Small cell carcinoma (SmCC) of the parotid gland

Small cell carcinoma, which is most often a pulmonary neoplasm, represents 25% to 35% of primary lung tumors.¹ Extensive lung SmCC has an 8-month median survival rate, and limited-stage disease has a 5-year survival rate of 5% to 10% despite the standard treatment of combined chemotherapy and radiation therapy.² Only 4% of SmCCs arise from extrapulmonary sites,³ including the head and neck region, gastrointestinal tract, pancreas, uterine cervix, endometrium, bladder, prostate, kidneys, thymus, and breast.³ The most common location of SmCC in the head and neck is the larynx.⁴ Small cell carcinoma can also involve the minor salivary glands, nasal cavity, paranasal sinuses, major salivary glands, and, rarely, trachea, oral cavity, and oropharynx.^4-5 Small cell carcinoma of the major salivary glands most commonly develops in the parotid gland.³

Histopathologic examination of our patient's parotid mass showed poorly differentiated cancer with sheets of closely packed dark cells with focal nuclear crushing, . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Pathology Quiz Case 1
Hari Nadiminti, Giovana R. Thomas, and Jacinto Regalado
Arch Otolaryngol Head Neck Surg. 2004;130(4):474.
EXTRACT | FULL TEXT